The role of EphA2 in KRAS mutant non-small cell lung cancer

被引：0
|
作者：
Amato, Katherine [1 ]
Wang, Shan [1 ]
Hastings, Andrew [1 ]
Chen, Haiying [2 ]
Colvin, Daniel [1 ]
Ye, Fei [1 ]
Chen, Jin [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
[2] Univ Melbourne, Melbourne, Vic, Australia
来源：
MOLECULAR CANCER RESEARCH | 2014年 / 12卷
关键词：
D O I：
10.1158/1557-3125.RASONC14-A01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A01
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Role of imunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival
    Amanam, Idoroenyi
    Mambetsariev, Isa
    Gupta, Rohan
    Achuthan, Srisairant
    Wang, Yingyu
    Pharaon, Rebecca
    Massarelli, Erminia
    Koczywas, Marianna
    Reckamp, Karen
    Salgia, Ravi
    JOURNAL OF THORACIC DISEASE, 2020, 12 (09) : 5086 - +
  • [22] Targeting KRAS in Non-Small Cell Lung Cancer
    Corral de la Fuente, Elena
    Olmedo Garcia, Maria Eugenia
    Gomez Rueda, Ana
    Lage, Yolanda
    Garrido, Pilar
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [23] The role of YAP signaling in KRAS driven non-small cell lung cancer
    Keil, Marina
    Schneider, Richard
    Trivier, Elisabeth
    Dillon, Christian
    Wienke, Dirk
    Seshire, Anita
    Pudelko, Linda
    Blaukat, Andree
    Karachaliou, Niki
    CANCER RESEARCH, 2020, 80 (16)
  • [24] Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non-Small Cell Lung Cancer
    Brannan, Jennifer M.
    Dong, Wenli
    Prudkin, Ludmila
    Behrens, Carmen
    Lotan, Reuben
    Bekele, B. Nebiyou
    Wistuba, Ignacio
    Johnson, Faye M.
    CLINICAL CANCER RESEARCH, 2009, 15 (13) : 4423 - 4430
  • [25] Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer
    Li, Ning
    Liu, Shaohui
    Sun, Mingjiao
    Chen, Wei
    Xu, Xiaogang
    Zeng, Zhu
    Tang, Yemin
    Dong, Yongquan
    Chang, Alex H.
    Zhao, Qiong
    TRANSLATIONAL ONCOLOGY, 2018, 11 (01): : 11 - 17
  • [26] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
    Jacqueline V. Aredo
    Sukhmani K. Padda
    Current Treatment Options in Oncology, 2018, 19
  • [27] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Giorgia Maroni
    Mahmoud A. Bassal
    Indira Krishnan
    Chee Wai Fhu
    Virginia Savova
    Rapolas Zilionis
    Valerie A. Maymi
    Nicole Pandell
    Eva Csizmadia
    Junyan Zhang
    Barbara Storti
    Julio Castaño
    Riccardo Panella
    Jia Li
    Corinne E. Gustafson
    Sam Fox
    Rachel D. Levy
    Claire V. Meyerovitz
    Peter J. Tramontozzi
    Kimberly Vermilya
    Assunta De Rienzo
    Stefania Crucitta
    Daniela S. Bassères
    Marla Weetall
    Art Branstrom
    Alessandra Giorgetti
    Raffaele Ciampi
    Marzia Del Re
    Romano Danesi
    Ranieri Bizzarri
    Henry Yang
    Olivier Kocher
    Allon M. Klein
    Robert S. Welner
    Raphael Bueno
    Maria Cristina Magli
    John G. Clohessy
    Azhar Ali
    Daniel G. Tenen
    Elena Levantini
    Communications Biology, 4
  • [28] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Maroni, Giorgia
    Bassal, Mahmoud A.
    Krishnan, Indira
    Fhu, Chee Wai
    Savova, Virginia
    Zilionis, Rapolas
    Maymi, Valerie A.
    Pandell, Nicole
    Csizmadia, Eva
    Zhang, Junyan
    Storti, Barbara
    Castano, Julio
    Panella, Riccardo
    Li, Jia
    Gustafson, Corinne E.
    Fox, Sam
    Levy, Rachel D.
    Meyerovitz, Claire, V
    Tramontozzi, Peter J.
    Vermilya, Kimberly
    De Rienzo, Assunta
    Crucitta, Stefania
    Basseres, Daniela S.
    Weetall, Marla
    Branstrom, Art
    Giorgetti, Alessandra
    Ciampi, Raffaele
    Del Re, Marzia
    Danesi, Romano
    Bizzarri, Ranieri
    Yang, Henry
    Kocher, Olivier
    Klein, Allon M.
    Welner, Robert S.
    Bueno, Raphael
    Magli, Maria Cristina
    Clohessy, John G.
    Ali, Azhar
    Tenen, Daniel G.
    Levantini, Elena
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [29] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
    Aredo, Jacqueline V.
    Padda, Sukhmani K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)
  • [30] Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
    Desage, Anne-Laure
    Leonce, Camille
    Swalduz, Aurelie
    Ortiz-Cuaran, Sandra
    FRONTIERS IN ONCOLOGY, 2022, 12
12345